These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15781835)

  • 41. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
    Snoeck E; Stockis A
    Epilepsy Res; 2007 Mar; 73(3):284-91. PubMed ID: 17196793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific effect of levetiracetam in experimental human pain models.
    Enggaard TP; Klitgaard NA; Sindrup SH
    Eur J Pain; 2006 Apr; 10(3):193-8. PubMed ID: 15946871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.
    Cicolin A; Magliola U; Giordano A; Terreni A; Bucca C; Mutani R
    Epilepsia; 2006 Jan; 47(1):82-5. PubMed ID: 16417535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new antiepileptic drug.
    Shorvon SD; van Rijckevorsel K
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Salemi JL; Siraj S; Wilson MC; Sullivan KL
    Mov Disord; 2007 Aug; 22(11):1660-3. PubMed ID: 17580330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Pease Campbell JA; Sullivan KL
    Mov Disord; 2007 Jan; 22(1):139-41. PubMed ID: 17089400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of levetiracetam XR 500mg tablets.
    Rouits E; Burton I; Guénolé E; Troenaru MM; Stockis A; Sargentini-Maier ML
    Epilepsy Res; 2009 Apr; 84(2-3):224-31. PubMed ID: 19264451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
    Frucht SJ; Louis ED; Chuang C; Fahn S
    Neurology; 2001 Sep; 57(6):1112-4. PubMed ID: 11571347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levetiracetam in spinal cord injury pain: a randomized controlled trial.
    Finnerup NB; Grydehøj J; Bing J; Johannesen IL; Biering-Sørensen F; Sindrup SH; Jensen TS
    Spinal Cord; 2009 Dec; 47(12):861-7. PubMed ID: 19506571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.
    Frucht SJ; Houghton WC; Bordelon Y; Greene PE; Louis ED
    Neurology; 2005 Dec; 65(12):1967-9. PubMed ID: 16382538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of inertial loading on wrist postural tremor in essential tremor.
    Héroux ME; Pari G; Norman KE
    Clin Neurophysiol; 2009 May; 120(5):1020-9. PubMed ID: 19383570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levetiracetam-induced depression in a healthy adult.
    Wier LM; Tavares SB; Tyrka AR; Price LH; Carpenter LL
    J Clin Psychiatry; 2006 Jul; 67(7):1159-60. PubMed ID: 16889466
    [No Abstract]   [Full Text] [Related]  

  • 58. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P; Sadzot B; Fejerman N; Peltola J; Despland PA; Steinhoff B; Rektor I; Wroe S; Maubrey MC; Vandervelden C; van Hammée G; Schlit AF; van Paesschen W
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preemptive levetiracetam decreases postoperative pain in rats.
    Sliva J; Dolezal T; Prochazkova M; Votava M; Krsiak M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):953-7. PubMed ID: 19112399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of levetiracetam in Huntington disease.
    de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
    Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.